Abbott To Market I-Stat POC Blood Analyzer Worldwide Under Aug. 4 Alliance
This article was originally published in The Gray Sheet
Abbott is rounding out its hospital point-of-care testing portfolio and providing I-Stat with access to a worldwide network of direct sales representatives through a long-term sales, marketing and research alliance announced Aug. 4 at the American Association for Clinical Chemistry conference in Chicago.
You may also be interested in...
i-STAT will be assured access to Abbott's brain natriuretic peptide (BNP) marker to develop a point-of-care myocardial infarction diagnostic if a proposed $392 mil. merger is approved by i-STAT shareholders
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.